How can we, humans, look at our relationship to nature differently? In season three of Going Wild, on top of stories about animals, we invite you to journey through the entire ecological web — from the tiniest of life forms to apex predators — alongside the scientists, activists and adventurers who study it. Wildlife biologist and host Dr. Rae Wynn-Grant has been studying wild animals in their natural habitats all over the world for years. Our award-winning podcast takes you inside the hidde ...
…
continue reading
Kandungan disediakan oleh Sano Genetics. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Sano Genetics atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
Player FM - Aplikasi Podcast
Pergi ke luar talian dengan aplikasi Player FM !
Pergi ke luar talian dengan aplikasi Player FM !
EP 113: Harnessing human genetics to discover co-evolved small molecule medicines with Dr. Jason Park, CEO of Empress Therapeutics
MP3•Laman utama episod
Manage episode 388131882 series 2631947
Kandungan disediakan oleh Sano Genetics. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Sano Genetics atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
In this episode of The Genetics Podcast, we welcome Dr. Jason, founder and CEO of Empress Therapeutics, a Flagship Pioneering company. Join us as we discuss how human genetics can identify small molecules with therapeutic potential that are already created by our bodies, paving the way for faster discovery of new medicines.
Summary:
Summary:
0:00 Intro
1:20 Understanding parts of the genome that create and modify small molecules
5:50 The central dogma of molecular biology
8:50 Jason’s background founding biotech companies
11:45 Flagship pioneering: combining scientific discovery and engineering innovations
13:10 The foundation of Empress Therapeutics: biological insight, data, and artificial intelligence
19:30 Learning from disease states and following the thread from DNA to small molecule
22:20 Differences in genetic chemistry across people and case studies
25:30 Potential biological limitations of the small molecule approach
28:00 Using human genetics and synthetic biology to create impactful medicines
32:00 What happens in ‘stealth mode’
36:00 The limiting reactant of scaling small molecule therapies to a wider platform
38:20 The role of the metagenome
40:00 Lessons learned from founding multiple companies
42:20 Origins of the name Empress Therapeutics
43:40 Closing remarks
187 episod
MP3•Laman utama episod
Manage episode 388131882 series 2631947
Kandungan disediakan oleh Sano Genetics. Semua kandungan podcast termasuk episod, grafik dan perihalan podcast dimuat naik dan disediakan terus oleh Sano Genetics atau rakan kongsi platform podcast mereka. Jika anda percaya seseorang menggunakan karya berhak cipta anda tanpa kebenaran anda, anda boleh mengikuti proses yang digariskan di sini https://ms.player.fm/legal.
In this episode of The Genetics Podcast, we welcome Dr. Jason, founder and CEO of Empress Therapeutics, a Flagship Pioneering company. Join us as we discuss how human genetics can identify small molecules with therapeutic potential that are already created by our bodies, paving the way for faster discovery of new medicines.
Summary:
Summary:
0:00 Intro
1:20 Understanding parts of the genome that create and modify small molecules
5:50 The central dogma of molecular biology
8:50 Jason’s background founding biotech companies
11:45 Flagship pioneering: combining scientific discovery and engineering innovations
13:10 The foundation of Empress Therapeutics: biological insight, data, and artificial intelligence
19:30 Learning from disease states and following the thread from DNA to small molecule
22:20 Differences in genetic chemistry across people and case studies
25:30 Potential biological limitations of the small molecule approach
28:00 Using human genetics and synthetic biology to create impactful medicines
32:00 What happens in ‘stealth mode’
36:00 The limiting reactant of scaling small molecule therapies to a wider platform
38:20 The role of the metagenome
40:00 Lessons learned from founding multiple companies
42:20 Origins of the name Empress Therapeutics
43:40 Closing remarks
187 episod
Όλα τα επεισόδια
×Selamat datang ke Player FM
Player FM mengimbas laman-laman web bagi podcast berkualiti tinggi untuk anda nikmati sekarang. Ia merupakan aplikasi podcast terbaik dan berfungsi untuk Android, iPhone, dan web. Daftar untuk melaraskan langganan merentasi peranti.